Cancer-associated antigen

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8946390
APP PUB NO 20130243799A1
SERIAL NO

13750849

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VIVENTIA BIO INC147 HAMELIN STREET WINNIPEG MB R3T 3Z1

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chahal, Francina C Calgary, CA 14 62
Cizeau, Jeannick Winnipeg, CA 22 93
MacDonald, Glen Winnipeg, CA 12 55

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 3, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00